Skip to search formSkip to main contentSkip to account menu

Levetiracetam 500 MG Oral Tablet [Keppra]

Known as: Keppra 500 MG Oral Tablet, LEVETIRACETAM 500 mg ORAL TABLET, FILM COATED [Keppra] 
National Institutes of Health

Related topics

Related topics

16 relations
Aluminum OxideCroscarmellose SodiumFD&C yellow no. 6Keppra

Broader (1)

Levetiracetam 500 MG Oral Tablet

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Brand‐to‐generic levetiracetam switching: a 4‐year prospective observational real‐life study
The purpose of this study was to determine whether switching from branded levetiracetam (Keppra®) to a levetiracetam generic… 
2017
2017
Validation of an Automated Assay for Levetiracetam (Keppra) on Vitros 5600.
OBJECTIVE Levetiracetam (also known as Keppra™) is an antiepileptic drug that has been demonstrated as an effective adjunctive… 
Review
2017
Review
2017
A New-born with Severe Hydrocephalus and Myelomeningocele Associated with Maternal Antiepileptic Medication: A Case Report
The possible teratogenic effects of maternal antiepileptic drugs (AEDs) on the development of the fetus are of major concern. The… 
2017
2017
Impact of generic substitution on levetiracetam serum concentration—A prospective study in an outpatient setting
Review
2016
Review
2016
Levetiracetam (Keppra): Evidence-Based Polypharmacy in Two Patients With Epilepsy
Introduction: Epilepsy is a prolonged disorder characterized by repeated violent epileptic seizures. Its managements depend on… 
2012
2012
Postmortem levetiracetam (Keppra®) data from North Carolina.
Levetiracetam (Keppra®) is one of the newer anticonvulsant drugs used to treat seizures. Since 2003, the North Carolina Office of… 
Review
2012
Review
2012
Incidence of Congenital Malformations in Infants Born to Patients with Epilepsy: A Comparison of Pregnancy Registries and Cohort Study Data (S56.003)
Objective: To compare rates of major congenital malformations (MCM) and ventricular septal defects (VSD) within the UCB AED… 
2010
2010
Levetiracetam in der Zusatzbehandlung von Säuglingen und Kleinkindern mit fokalen Anfällen
ZusammenfassungLevetiracetam (LEV, Keppra®) wurde im Jahr 2004 in Deutschland für die Zusatzbehandlung fokaler Epilepsien bei… 
2007
2007
Levetiracetam (Keppra®): errores de dosificación asociados a la administración de concentrado para solución para perfusión : (Nota informativa de la AEMPS 2007/16, de 15 de noviembre de 2007)
La Agencia Espanola de Medicamentos y Productos Sanitarios (AEMPS), a traves del Grupo de Trabajo de Farmacovigilancia Europeo… 
2007
2007
MP-10.08: Effect of an antiepileptic - Levetiracetam (Keppra™) - on neurogenic overactive bladder in chronic paraplegic rats
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)